Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$347K Buy
40,543
+31,509
+349% +$280K ﹤0.01% 4627
2014
Q2
$81K Buy
9,034
+4,181
+86% +$37.6K ﹤0.01% 6208
2014
Q1
$51K Buy
4,853
+2,695
+125% +$29.7K ﹤0.01% 6789
2013
Q4
$19K Buy
2,158
+1,933
+859% +$18.9K ﹤0.01% 8203
2013
Q3
$2K Sell
225
-1,775
-89% -$13.8K ﹤0.01% 9935
2013
Q2
$11K Buy
+2,000
New +$11.3K ﹤0.01% 8521

Other funds holding CGEN

UBS's CGEN Position: Q3 2014 in Review

UBS increased its Compugen (CGEN) stake by 349% in Q3 2014, buying an estimated $280K and bringing the position to 40,543 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #4627.

UBS first reported a position in CGEN in Q2 2013 and has held it in 6 quarters since. 38 funds tracked by Wall St. Rank hold CGEN as of Q3 2014.

  • UBS held 40,543 shares of Compugen worth $347K as of Q3 2014.
  • UBS bought 31,509 Compugen shares in Q3 2014, an estimated $280K.
  • Compugen made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4627 holding.
  • UBS first reported a position in Compugen in Q2 2013 and has held it in 6 quarters since.
  • 38 funds tracked by Wall St. Rank held Compugen as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.